Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice
Authors:
- Yamei GaoYGYamei Gao
- Driss EhirchiouDEDriss Ehirchiou
- Chunzhang CaoCCChunzhang Cao
- Takashi KikuiriTKTakashi Kikuiri
- Anh LeALAnh Le
- Songtao ShiSSSongtao Shi
- Li ZhangLZLi Zhang
- 1 July 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 177 (1) , 280-290
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI078365, HL054710)
- National Institute of Dental and Craniofacial Research
- Division of Intramural Research
This publication has 26 references indexed in Scilit:
- Giant Osteoclast Formation and Long-Term Oral Bisphosphonate TherapyNew England Journal of Medicine, 2009
- Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2007
- Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their nicheNature Medicine, 2007
- Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone diseaseNature Clinical Practice Oncology, 2007
- Osteonecrosis of the Jaw and BisphosphonatesNew England Journal of Medicine, 2005
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- DocetaxelDrugs, 2005
- Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)International Journal of Cancer, 2003
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987